Researchers complete final analysis of a phase 3 study of men with hemophilia B receiving intravenous etranacogene dezaparvovec.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/hemophilia-b-gene-therapy-continues-reduce-bleeding-2026a10002fm?src=rss
Author :
Publish date : 2026-01-26 15:53:00
Copyright for syndicated content belongs to the linked Source.
